- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07802600
Clinical, Dermoscopic, and Mycological Characteristics of Tinea Capitis in Children
Clinical, Dermoscopic, and Mycological Characteristics of Tinea Capitis in Children: A Cross-sectional Study
Visão geral do estudo
Status
Condições
Descrição detalhada
Clinical types of tinea capitis include : scaly type (characterized by fine scaling and circular alopecia), black dot (characterized by non-inflammatory patches with broken-off, swollen hair stubs), tinea agminate (patchy alopecia with scattered pustules or low-grade folliculitis), kerion (painful, boggy, inflammatory masses with alopecia, often confused with bacterial abscess) and favus (scutula, mousy odor) . Tinea incognito (steroid modified tinea) refers to dermatophytosis that has lost their usual clinical appearance due to the use of steroids.
The main clinical feature of dermatophyte scalp infections is the appearance of scaling of the scalp skin, which is associated with a variable degree of inflammation and itching . In some cases, the infection closely resembles seborrheic dermatitis or dandruff of the scalp. A pathognomonic feature is hair loss; hair often breaks a few millimeters or more above the skin surface. Broken or infected hairs are also slightly swollen and have a dull appearance .
Trichoscopy is a non-invasive and very useful technique for the diagnosis and follow-up of hair and scalp disorders. The presence of certain trichoscopic features allows accurate identifying of tinea capitis. In tinea capitis, specific signs can be seen like comma hair, corkscrew hair, bar code-like hair and zigzag hair . In tinea incognito trichoscopic finding include erythema, scaling, bent hair, Morse code hair, and micropustules .
Mycological examination was first performed using Potassium Hydroxide(KOH) to confirm the diagnosis of tinea capitis where the patients with positive KOH were considered to have endothrix when observing arthroconidia inside the hair shaft and ectothrix when observing arthroconidia outside the hair shaft. The fungal culture also done to accurately recognize the organism through inoculation of samples on Sabouraud medium agar (SDA) with and without chloramphenicol(nonspecific medium) . And Dermasel medium agar act as specific medium.
The increase in antifungal resistance has recently been observed worldwide and resistant strains of the dermatophytes T. rubrum and T. indotineae have spread globally, causing outbreaks of extensive, difficult to treat infections , so we need rapid and reliable diagnostic tools that provide clues regarding the causative organisms.
Tipo de estudo
Inscrição (Estimado)
Contactos e Locais
Contato de estudo
- Nome: Noha Shafik, Assistant professor
- Número de telefone: 01067261504
- E-mail: nohasaber@med.sohag.edu.eg
Estude backup de contato
- Nome: Walaa Hemdan Abu Alhassan, Demonstrator
Locais de estudo
-
-
-
Sohag, Egito
- Faculty of Medicine , Sohag university
-
Contato:
- Noha Shafik
- Número de telefone: 01067261504
- E-mail: nohasaber@med.sohag.edu.eg
-
Contato:
- Walaa Hemdan
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
- Adulto
Aceita Voluntários Saudáveis
Método de amostragem
População do estudo
The study will be conducted at the Dermatology Outpatient Clinic in Sohag University Hospitals.
Study population: The study population will be all patients with tinea capitis both male and female in childhood period, Aged 1-18 years old
Descrição
Inclusion Criteria:
- Both male and female in childhood period (1-18 years) with tinea capitis
Exclusion Criteria:
- Topical or systemic antifungal medications one month prior to enrollment in the study
- Presence of systemic disease, such as hepatic,renal, cardiac, autoimmune diseases, or malignancy
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
|---|---|
|
patients with tinea capitis both male and female in childhood period
|
Specimen will be cultured on sabouraud's dextrose agar (SDA) at 25 -30 c for 2 to 4 weeks and another specimen will be cultured on a Dermasel agar base (Oxoid, UK), both supplemented with chloramphenicol and cycloheximide , staining the fungal colonies by Lactophenol cotton blue to help the examination of colonial morphology and microscopic examination of the macro-conidia allow the identification of the dermatophyte species and suitable treatment
Antifungal susceptibility testing will be performed to determine the specific sensitivity profiles of the fungal isolates.
Antifungal susceptibility testing will be performed using seven antifungal agents: Terbinafine, Itraconazole, Griseofulvin, Fluconazole, Ketoconazole, Vorioconole and Miconazole.
Dermatophytes colonies will be probed from Dermasel agar cultures.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Percentage of participants presenting with specific clinical patterns of tinea capitis
Prazo: At the time of initial clinical evaluation
|
Clinical evaluation will be performed to identify and classify the presentation of tinea capitis lesions (e.g., scaly patches, black dots, kerion, favus).
|
At the time of initial clinical evaluation
|
|
Percentage of participants exhibiting specific dermoscopic features of tinea capitis
Prazo: At the time of initial dermoscopic evaluation
|
Dermoscopic examination using a handheld dermatoscope to identify characteristic signs including comma hairs, corkscrew hairs, broken hairs, and scaling.
|
At the time of initial dermoscopic evaluation
|
|
Prevalence of isolated fungal species among pediatric tinea capitis cases
Prazo: At the time of initial sample collection and culture identification
|
Mycological evaluation including direct microscopic KOH preparation and fungal culture on agar media to isolate and identify the causative fungal pathogens.
|
At the time of initial sample collection and culture identification
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Cadeira de estudo: Mohammed Abu El Hamd Ali, Faculty of Medicine , Sohag university
- Cadeira de estudo: Doaa Gaber Abdelbaset, Faculty of Medicine , Sohag university
Publicações e links úteis
Links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- Soh-Med-26-8-10MS
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .